With half of the American population receiving health insurance from their jobs, there’s no doubt that employers are at the forefront of rising healthcare costs. But many employers may feel helpless in the face of industries seemingly out of their control — and the trillion-dollar pharmaceutical industry is no exception.
Real value is achieved by focusing on whole-person health and clinical appropriateness. In this study, one patient case led to more than $48,000 in clinical savings while managing the patient’s quality of life on the new medication recommendation! You’ll see how our population health model drove over $4MM in savings and personalized patient care since client implementation.